|
|
|
|
||
New ADA guidelines for Type 1 diabetics list Afrezza as SOCVery substantial designation for MNKD and Afrezza. Just came out today will be interesting to see how market responds over the next week(s) as this data becomes more distributed and discussed. Will surely help with Insurers and PBM's in 2019. |
return to message board, top of board |